Author

Jie Zhang 1

1 The First Affiliated Hospital, College of Medicine, Zhejiang University,Hangzhou,China

3-Mercaptopyruvate sulfurtransferase represses tumor progression and predicts prognosis in hepatocellular carcinoma

Meng Li, Qi Jin, Jie Zhang, Li Cen, Chaohui Yu, Youming Li

EARLY ACHIEVEMENT OF PARTIAL MAYO SCORE REMISSION AND IBDQ NORMALIZATION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FILGOTINIB IN THE PHASE 2B/3 SELECTION STUDY

Marc Ferrante, Alessandra Oortwijn, Chohee Yun, Jie Zhang, Laurent Peyrin-Biroulet, Severine Vermeire, Silvio Danese, Brian Feagan

EFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIALEFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIAL

Laurent Peyrin-Biroulet, Iris Dotan, Alessandra Oortwijn, Brian Feagan, Toshifumi Hibi, Virginia Taliadouros, Sally Zhao, Jie Zhang, Jeremy Hsieh

FULL-THICKNESS PERORAL ENDOSCOPIC MYOTOMY (POEM) FOR THE TREATMENT OF SIGMOID-TYPE ACHALASIA: A COMPARATIVE STUDY OF CONVENTIONAL AND MODIFIED POEM

Liang Lyu, Jia Liu, Yuyong Tan, Jie Zhang, Meixian Le, Deliang Liu

RAPIDITY OF SYMPTOM IMPROVEMENTS DURING FILGOTINIB INDUCTION THERAPY IN PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY

Silvio Danese, Timothy Ritter, Jason Dinoso, Jeremy Hsieh, Chohee Yun, Jie Zhang, Sally Zhao, Edward V Loftus Jr, Toshifumi Hibi, Gerhard Rogler

The methodology, feasibility and safety of colonic transendoscopic enteral tubing: a multicenter, randomized controlled trial

Quan Wen, Bota Cui, Pan Li, Jie Zhang, Xia Wu, Hua Tu, Yu Yuan, Faming Zhang

Item 1 - 6 / 7
1